Telehealth Pill Mill Unleashed

Hand holding pen, filling out lawsuit form.

A telehealth startup that promised easy online ADHD care has now been branded a national “pill mill,” after its founder was sentenced for flooding America with tens of millions of Adderall pills through a subscription app.

Story Snapshot

Founder Ruthia He gets six years in prison and a $1 million fine for a massive Adderall scheme.
Her company, Done Global, used its tech platform to push over 37 million Adderall pills and steal more than $12 million from insurers.
Clinical president David Brody prescribed hundreds of thousands of stimulant pills to patients he never properly assessed.
The case marks a wider federal crackdown on telehealth “pill mills” that many see as proof the system let profit trump patient safety.

Telehealth CEO Sentenced for Massive Adderall Scheme

Federal prosecutors say Done Global, a San Francisco-based online mental health company, turned remote ADHD care into a high-speed pipeline for Adderall prescriptions. Founder and former chief executive officer Ruthia He was sentenced to six years in prison and fined $1 million for orchestrating the operation. According to the Department of Justice, her team used the company’s app, payment system, and clinical rules to unlawfully distribute more than 37 million Adderall pills nationwide and commit health care fraud.

The scheme did not just involve too many prescriptions; it also involved lying to insurance companies to get paid. Court documents say Done Global and its leaders defrauded Medicare, Medicaid, and private insurers out of about $12.3 million by submitting claims for stimulants that did not have a valid medical basis. Prosecutors describe the plan as a $90 million operation built to reach a $1 billion company value by trading safe medical judgment for fast growth and subscription revenue.

Assembly-Line Prescribing and Deceptive Advertising

Evidence at trial showed how the rush for profit reshaped basic medical care inside Done Global. Clinicians tied to the platform issued Adderall prescriptions at intervals as short as thirty seconds, a pattern that observers called “assembly-line prescribing,” far from careful, one-on-one patient evaluation. Clinical president David Brody personally prescribed 394,324 stimulant pills to large numbers of patients he never properly assessed, underscoring how technology was used to push speed over safety.

Government investigators say the company backed this high-speed prescribing with a huge online marketing push. Done Global and He spent more than $40 million on social media ads during and after the COVID-19 pandemic, targeting people who felt unfocused working from home or aging and telling them they likely had ADHD that needed Adderall. For many Americans already worried about “Big Tech” and “Big Health” playing with their emotions to make money, these ads look less like care and more like manipulation at scale.

Convictions, Co-Defendant Sentence, and Wider Crackdown

In November 2025, a federal jury in San Francisco convicted He and Brody on one count of conspiracy to distribute controlled substances, four counts of distributing controlled substances, and one count of conspiracy to commit health care fraud. He was also found guilty of conspiracy to obstruct justice, though public documents do not spell out all the steps she took to interfere with the investigation. These convictions made Done Global one of the first telehealth firms ever prosecuted criminally for drug distribution.

Brody, the company’s former clinical president, received a separate sentence of two years in prison and a $1 million fine. Federal agencies including the Drug Enforcement Administration, Internal Revenue Service Criminal Investigation, the Office of Inspector General for Health and Human Services, and Homeland Security Investigations worked together on the case, treating Done Global as part of a larger pattern of pandemic-era telehealth fraud. Officials have said these kinds of schemes helped fuel addiction and overdose, deepening public anger at a health system many already see as serving money over patients.

What This Case Signals for Patients, Doctors, and the System

This case lands at a time when Americans across the political spectrum feel betrayed by powerful institutions, including both government and big health companies. Done Global promised fast, easy access to ADHD treatment, which sounded like a win for patients shut out of traditional care. Instead, investigators say the company used those hopes to sell pills at industrial volume and bill insurers for care that did not follow basic medical rules. For families watching loved ones battle addiction, that looks less like innovation and more like high-tech drug dealing backed by investor cash.

Psychiatrist David Brody gets two years prison for Adderall distribution scheme

Former Done Global Clinical President Dr. David Brody has been sentenced to two years in federal prison and fined $1 million for his role in a multimillion-dollar telehealth scheme that illegally…

— PsychCrime (@psychcrime) July 9, 2026

Federal agencies are now using this case as a warning to the broader telehealth industry. Reports on telehealth fraud show that a small share of providers used virtual care to drive suspicious billing and over-prescribing, raising costs and risk for everyone, while most tried to offer honest service. The Done Global story highlights how emergency rules from the pandemic, meant to help patients, also opened the door for aggressive actors to game the system. Many citizens will see this as yet another example of elites bending rules for profit while ordinary Americans bear the health and financial damage.